Clovis Oncology, Inc., along with its two affiliates, filed a voluntary petition for reorganization under Chapter 11 in the US Bankruptcy Court for the District of Delaware on December 11, 2022. The debtor listed its assets in the range of $100 million to $500 million and liabilities in the range of $500 million to $1 billion. The debtor is represented by Robert J. Dehney of Morris, Nichols, Arsht & Tunnell LLP as its legal counsel and Willkie Farr & Gallagher LLP is appointed as bankruptcy co-counsel.

Alix Partners, LLP is appointed as restructuring advisor, Perella Weinberg Partners LP is appointed as investment banker and Prime Clerk LLC has been appointed as claims and noticing agent.